
Hofseth BioCare Investor Relations Material
Latest events

Q2 2025
22 Aug, 2025

Q1 2025
16 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hofseth BioCare
Access all reports
Hofseth BioCare ASA is a biotechnology company that focuses on the production of high-value ingredients derived from fish. The company develops and commercializes sustainable biomarine products for human and pet health. Its product portfolio includes bioactive peptides, oils, calcium, and proteins, which are used in a variety of industries, including dietary supplements, clinical nutrition, and functional foods. Hofseth BioCare emphasizes utilizing fresh raw materials and applying a gentle enzymatic hydrolysis process to retain the nutritional properties of the fish. The company is headquartered in Ålesund, Norway, and its shares are listed on the Oslo Stock Exchange.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
HBC
Country
🇳🇴 Norway